The occurrence of cancer in nine recipients — two of which involved evidence that a viral delivery tool integrated into ...

Today, a brief rundown of news involving Eli Lilly and Alnylam Pharmaceuticals, as well as updates from Servier, Ultragenyx, Boehringer Ingelheim and ANI Pharmaceuticals that you may have missed.

The latest installment in BioPharma Dive’s visualization-focused series features a look at investors’ response to a trio of ...